BPO Share Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A
52 Week Low N/A
BPO Important Levels
Resistance 2 N/A
Resistance 1 N/A
Pivot N/A
Support 1 N/A
Support 2 N/A
ASX Australia Most Active Stocks
AYR 0.01 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
AGO 0.05 25.00%
AGO 0.05 25.00%
AGO 0.05 25.00%
DDD 0.01 0.00%
DDD 0.01 0.00%
DDD 0.01 0.00%
BUR 0.02 0.00%
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RHT 0.03 50.00%
RHT 0.03 50.00%
EXG 0.03 50.00%
EXG 0.03 50.00%
CDY 0.03 50.00%
CDY 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
GPP 0.02 -33.33%
BMN 0.04 -20.00%
ICP 0.04 -20.00%
ICP 0.04 -20.00%

BioProspect Ltd (ASX: BPO)

BPO Technical Analysis 1
As on N/A BPO Share Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
BPO Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
BPO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioprospect.com
BPO Address
145 Stirling Highway
Suite 25
Nedlands, WA 6009
Phone: 61 8 9389 3170
Fax: 61 8 9389 3199
BPO Latest News
VC Score In Focus for Medibio Limited (ASX:MEB)   Marion Business Daily   - 04th Jan 17
Reviewing Indicator Levels for Medibio Limited (MEB.AX)   StockTalk Daily   - 04th Jan 17
BRIEF-Medibio enters into binding agreement with Medtronic   Reuters   - 24th Nov 16
BRIEF-Medibio Ltd raises $13.5 mln   Reuters   - 18th Nov 16
Medibio Ltd to outline major raising   Proactive Investors Australia   - 16th Nov 16
Medibio Ltd joins Monash University to develop mental health solutions   Proactive Investors Australia   - 14th Sep 16
Medibio Ltd to reveal results   Proactive Investors Australia   - 05th Aug 16
Medibio cashes up as market-ready mental health products develop   Proactive Investors Australia   - 18th Sep 15
What's Happening to the Share Price of Medibio Ltd?   Daily Reckoning - Australian Edition   - 10th Aug 15
Medibio Limited produces first test to measure stress   Proactive Investors Australia   - 17th Jun 15
Interactive Technical Analysis Chart BioProspect Ltd ( BPO ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioProspect Ltd
BPO Business Profile
BioProspect Limited is engaged in the research, development, and commercialization of natural products and technology in the human health and personal care, animal health and nutrition, and agricultural sectors in Australia and internationally. The company offers agriculture/animal health products comprising Qcide, a natural insecticide for controlling hygiene insects, including flies, mosquitoes, and ants; AGRIPRO topical gel for the treatment of surface wounds and abrasions, and skin conditions; and GI-GUARD oral paste for horses. It also provides human health/skin care products, such as DEMURE natural skin care products, and L'AZURE cosmetics; and therapeutic products, including pain relief sprays and gels, and emu oil capsules under the REGEN brand. In addition, the company is involved in the oil and gas exploration and development activities primarily in the Philippines. BioProspect Limited was founded in 1998 and is based in Nedlands, Australia.